Several novel methoctramine-related tetraamines were designed, and their biological profiles at muscarinic receptor subtypes were assessed by functional experiments in isolated guinea pig and rat atria (M2) and smooth muscle (ileum and trachea, M3) and by binding assays in rat cortex (M1), heart (M2), and submaxillary gland (M3) homogenates and NG 108-15 cells (M4). Tripitramine, a nonsymmetrical tetraamine, resulted in the most potent and the most selective muscarinic M2 receptor antagonist of the series (pA2 = 9.14-9.85; pKi= 9.54). Spirotramine (FC 15-94), a symmetrical tetraamine, was able to differentiate between muscarinic m1 receptors (pKi = 7.88) and the other subtypes (M2, pKi = 6.20; M3, pKi =5.81; M4 pKi = 6.27). Thus, tripitramine and spirotramine could be valuable tools for the pharmacological classification and characterization of muscarinic receptor subtypes. © 1995.
The design of novel methoctramine-related tetraamines as muscarinic receptor subtype selective antagonists / Melchiorre C.; Minarini A.; Budriesi R.; Chiarini A.; Spampinato S.; Tumiatti V.. - In: LIFE SCIENCES. - ISSN 0024-3205. - STAMPA. - 56:11-12(1995), pp. 837-844. [10.1016/0024-3205(95)00018-2]
The design of novel methoctramine-related tetraamines as muscarinic receptor subtype selective antagonists
Melchiorre C.;Minarini A.;Budriesi R.;Chiarini A.;Spampinato S.;Tumiatti V.
1995
Abstract
Several novel methoctramine-related tetraamines were designed, and their biological profiles at muscarinic receptor subtypes were assessed by functional experiments in isolated guinea pig and rat atria (M2) and smooth muscle (ileum and trachea, M3) and by binding assays in rat cortex (M1), heart (M2), and submaxillary gland (M3) homogenates and NG 108-15 cells (M4). Tripitramine, a nonsymmetrical tetraamine, resulted in the most potent and the most selective muscarinic M2 receptor antagonist of the series (pA2 = 9.14-9.85; pKi= 9.54). Spirotramine (FC 15-94), a symmetrical tetraamine, was able to differentiate between muscarinic m1 receptors (pKi = 7.88) and the other subtypes (M2, pKi = 6.20; M3, pKi =5.81; M4 pKi = 6.27). Thus, tripitramine and spirotramine could be valuable tools for the pharmacological classification and characterization of muscarinic receptor subtypes. © 1995.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
